mannosamine has been researched along with epirubicin in 1 studies
Studies (mannosamine) | Trials (mannosamine) | Recent Studies (post-2010) (mannosamine) | Studies (epirubicin) | Trials (epirubicin) | Recent Studies (post-2010) (epirubicin) |
---|---|---|---|---|---|
144 | 0 | 44 | 5,453 | 1,838 | 1,570 |
Protein | Taxonomy | mannosamine (IC50) | epirubicin (IC50) |
---|---|---|---|
Genome polyprotein | 0.75 | ||
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 5.181 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alam, MA; Panda, AK; Singh, AT; Talegaonkar, S; Tariq, M | 1 |
1 other study(ies) available for mannosamine and epirubicin
Article | Year |
---|---|
Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Caco-2 Cells; Cell Survival; Drug Carriers; Drug Liberation; Epirubicin; Gastrointestinal Tract; Hexosamines; Humans; Ileum; Intestinal Absorption; Lactic Acid; MCF-7 Cells; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Wistar; Surface Properties | 2016 |